ResearcherPhilipps University of MarburgActive in the last 2 years
Felix S.R. Picard
Matched on ORCID iD 0000-0001-7624-4704; OpenAlex author ID A5071261626. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 43
2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper
Papers 4
- DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2023-331854↗
- IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Co-author DOI 10.1136/gutjnl-2022-327855↗
- IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Co-author DOI 10.1158/2326-6066.cir-22-0398↗
- New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. Co-author DOI 10.1053/j.gastro.2021.04.082↗
Closest collaborators
The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Magdalena Huber · 4 shared papers, 2021–2024 · strength 0.52
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Thomas Mathias Gress · 4 shared papers, 2021–2024 · strength 0.52
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Veronika Lutz · 3 shared papers, 2023–2024 · strength 0.44
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Corinna Ulrike Keber · 2 shared papers, 2023–2024 · strength 0.31
- Anna I. Brichkina · 2 shared papers, 2023–2024 · strength 0.29
- Detlef Klaus Bartsch · 2 shared papers, 2023–2024 · strength 0.29
- Matthias Lauth · 2 shared papers, 2023–2024 · strength 0.29
- Malte Buchholz · 2 shared papers, 2023 · strength 0.27
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Christian Alexander Bauer · 2 shared papers, 2023 · strength 0.27
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Shiv K. Singh · 2 shared papers, 2021–2023 · strength 0.21
- Carsten Denkert · 1 shared paper, 2024 · strength 0.16
- Peter Duewell · 1 shared paper, 2023 · strength 0.15
- Matthias M. Gaida · 1 shared paper, 2023 · strength 0.12
- Philipp Mayer · 1 shared paper, 2023 · strength 0.12
- Lukas Klein · 1 shared paper, 2023 · strength 0.12
- Mengyu Tu · 1 shared paper, 2023 · strength 0.12
- Robert Liefke · 1 shared paper, 2023 · strength 0.12
- Karin Feldmann · 1 shared paper, 2021 · strength 0.09
- Stephan B. Dreyer · 1 shared paper, 2021 · strength 0.09
- Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09
- Elisa Espinet · 1 shared paper, 2021 · strength 0.09
- Corinne Bousquet · 1 shared paper, 2021 · strength 0.09
- Andreas Trumpp · 1 shared paper, 2021 · strength 0.09
- Maximilian Reichert · 1 shared paper, 2021 · strength 0.09
- Steven A. Johnsen · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.